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Membrane protein structureIn our previous paper, we demonstrated that Arg 901 in the C-terminal tail of human AE1 (band 3, anion
exchanger 1) had a functional role in conformational change during anion exchange. To further examine
how Arg 901 is involved in conformational change, we expressed various Arg 901 mutants and alanine mu-
tants of the C-terminal tail (from Leu 886 to Val 911) on the plasma membrane of Saccharomyces cerevisiae
and evaluated the kinetic parameters of sulfate ion transport. As a result, Vmax decreased as the hydropho-
bicities of the 901st and peripheral hydrophilic residues increased, indicating that the hydrophobicity of
the C-terminal residue is involved in the conformational change. We also found the alkali and protease re-
sistance of the C-terminal region after Arg 901 modiﬁcation with hydroxyphenylglyoxal (HPG) or phenyl-
glyoxal (PG), a hydrophobic reagent. These results suggested that the increased hydrophobicity of the C-
terminal region around Arg 901 leads to inefﬁcient conformational change by the newly produced hydro-
phobic interaction.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Anion exchanger 1 (AE1 or band 3) facilitates the electro-neutral
exchange of Cl− for HCO3− across the plasma membrane as part of
the process of CO2 transport in the blood [1,2]. Human AE1 consists
of 911 amino acids and has two structurally and functionally distinct
domains [3]: a 40-kDa cytoplasmic domain (1–360) and a 55-kDa
membrane domain (361–911). The cytoplasmic domain interacts
with cytoskeleton proteins and maintains an erythrocyte shape.
The 55-kDa membrane domain penetrates the membrane 12–14
times and is responsible for anion exchange activity. Recently, the
three-dimensional structure of the outward-facing conformation of
the membrane domain was solved at 7.5 Å by electron microscopyaethyleneglycol monododecyl
iocyanostilbene-2,2-disulfonic
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l rights reserved.[4,5]. However, the relationship between structure and function
was still unsolved.
Kinetic studies showed that one-by-one exchange mediates the
anion exchange of AE1, as the “ping-pong” model indicates [6]. This
model suggests that a single substrate anion is transported through
a single conformational change between the inward-facing and
outward-facing conformations. Furthermore, studies of chemical
modiﬁcation and mutation suggested that some Lys, Glu, and His res-
idues are important for anion exchange [7–13].
Some studies suggested that arginine is also an important resi-
due for anion exchange. Wieth et al. [14,15] showed that chloride
exchange depended on the protonation of residue with an apparent
pK value of 12. In addition, anion transport was inhibited by
arginine-speciﬁc reagents such as phenylglyoxal (PG) [16], 1,2-
cyclohexanedione [17], and hydroxyphenylglyoxal (HPG) [18]. Our
previous protein chemical study revealed that HPG speciﬁcally
modiﬁed Arg 901, which is the most C-terminal arginine in the
membrane domain [19]. The HPG modiﬁcation prevented the reac-
tion of 4,4-diisothiocyanostilbene-2,2-disulfonic acid (DIDS), which
binds preferentially to the outward-facing conformation and thus
inhibits conformational change [7,20,21]. These ﬁndings suggested
that the modiﬁcation of Arg 901 by HPG ﬁxed AE1 to the inward-
facing conformation. Moreover, the Vmax value of R901A, by
which Arg 901 was mutated to alanine, decreased whereas the
Km value did not change. Therefore, we concluded that Arg 901
played an important role in conformational change rather than in
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is involved in conformational change.
In the present study, Arg 901 was mutated into various amino
acids and its peripheral residues into alanine. We then evaluated
the kinetic parameters of these mutants. In addition, we also exam-
ined the alkali and protease sensitivity of the C-terminal region by hy-
drophobic modiﬁcation with HPG or PG. The results demonstrated
that the increased hydrophobicity of the C-terminal tail in AE1 leads
to more rigid structure and thus inefﬁcient conformational change.
2. Materials and methods
2.1. Materials
Anti-Vma2p antibody was purchased from Molecular Probes, Inc.
(Eugene, OR). The BY4743 strain was purchased from Invitrogen
(Carlsbad, CA). Other chemical reagents were purchased from Wako
Pure Chemical Industries (Osaka, Japan).
2.2. Expression of AE1 on the yeast plasma membrane
The membrane domain (Gly 361~Val 911) of AE1 mutants, which
contain Arg 901 mutants (R901K, R901E, R901A, R901M, R901C,
R901I) and alanine mutants of peripheral residues in the C-terminal
region (L886A, D887A, D889A, D890A, K892A, T894A, F895A, D896A,
E897A, E898A, E899A, G900A, D902A, E903A, Y904A, D905A, E906A,
V907A,M909A, P910A, V911A)were constructed [22,23] and expressed
on the yeast membrane according to the previous papers [11,19]. In
belief, The pYES2-FHSHS and pGAD-C1 vectors co-transfected into
Saccharomyces cerevisiae strain BY4743 were cultured in leucine/uracil
minus medium containing 0.67% yeast nitrogen base, 1% succinate,
0.6% NaOH, 2% rafﬁnose, and 0.08% amino acid mix. When the optical
density at 600 nm became 0.7, 0.5–2% (w/v) galactose was added to
the culturedmedium to induce AE1 expression. The yeastswere collected
after 6 h. Yeasts of the same culture were separated for protease accessi-
bility and sulfate transport assays in each independent experiment.
2.3. Protease accessibility assay
The protease accessibility assay was used to measure AE1 expres-
sion on the plasma membrane [19,24]. In brief, we treated the collect-
ed cells with 0.1 M Tris–HCl (pH 8.0) containing 1.2 M sorbitol and
5 mg/ml chymotrypsin at 4 °C for 1 h. The chymotrypsin-treated
cells were washed three times with 0.1 M Tris–HCl (pH 8.0) contain-
ing 1.2 M sorbitol and 2 mM phenylmethanesulfonyl ﬂuoride (PMSF)
and were incubated with 1% 2-mercaptoethanol and 240 mM NaOH
at 4 °C for 1 h. The proteins were precipitated using trichloroacetic
acid (TCA) and acetone, and then were immunoblotted with anti-
Flag antibodies and anti-Vma2p antibodies. The gel images were visu-
alized using a phosphorimager (FLA2000; Fuji, Tokyo, Japan). Quanti-
tation was performed using MacBAS software (Fuji). By comparing
the band density between the AE1 expressed in the yeast and the
AE1 puriﬁed from the erythrocyte membrane, the absolute amount
of AE1 expressed in the yeast was calculated. And we measured the
density of the 22-kDa N-terminal fragment bands, which were pro-
duced by the cleavage of extracellular chymotrypsin. From the densi-
ty of 22-kDa fragments, we estimated the AE1 expression on the
plasma membrane. The AE1 cleavage was complete under these con-
ditions because longer chymotrypsin treatment did not increase the
amount of the cleaved 22-kDa fragments (data not shown).
2.4. Sulfate transport assay
A sulfate transport assay was carried out as described previously
[11,19]. In brief, the collected cells were concentrated by centrifuga-
tion (1000×g, 10 min), and then its OD600 was re-adjusted to 10 in5 mM HEPES buffer (pH 6.0) containing 200 mM sucrose, 25 mM
gluconate, 25 mM citrate, and 1 mM Na2SO4. Then, 0 or 10 μM DIDS
(ﬁnal concentration) was added to the cells. As described in the pre-
vious paper, about 25% of the sulfate uptake remained after DIDS
treatment [11]. This remaining uptake was not included in the kinet-
ic parameter calculation as DIDS-insensitive sulfate uptake. After
pre-incubation for 90 min at 30 °C, the assay was started by adding
from 5 to 160 mM Na2SO4 (ﬁnal concentration) containing 7.5 μCi
of 35SO42− (Amersham Biosciences, Piscataway, NJ). After 5 min incu-
bation at 30 °C and pH 6.0, the cells were trapped rapidly on a glass
ﬁlter and washed three times with distilled water. The cells were re-
suspended in Clear-sol I solution (Nacalai Tesque, Kyoto, Japan), and
then the radioactivity was measured by scintillation counting (Liquid
Scintillation Counter LSC-5100; Aloka, Tokyo, Japan). The inﬂux in
wild type AE1 expressing cell was about 5 μmol/min per mg AE1 at
an extracellular concentration of 100 mM Na2SO4. This value was
calculated using amount of plasma membrane expressed AE1
(40.5 μg per 1 l culture in wild type cell). In this case, the total radio-
activity on the ﬁlter after 5 min was 1640DPM, which was enough to
measure. The difference in 35SO42− incorporation in the absence or
presence of DIDS was calculated as AE1-speciﬁc 35SO42− incorpora-
tion [11,19].
2.5. Assay for evaluation of alkali and protease resistance in the
C-terminal region
Unsealed ghosts from human erythrocytes were prepared as de-
scribed previously [25]. One-milliliter aliquots of unsealed ghosts
(1 mg/ml) were treated with 0, 50 mM HPG or 10 mM PG for 1 h at
37 °C and pH 7.4 in standard buffer (5 mM HEPES (pH7.4) containing
200 mM sucrose, 25 mM gluconate, 25 mM citrate, and 1 mM
Na2SO4). After being washed three times with the standard buffer,
the ghosts were incubated with 50 mM NaOH at 4 °C for 30 min.
After centrifugation at 20,000 g for 30 min at 4 °C, the precipitated
ghosts were re-dissolved into 0.1 M Tris–HCl (pH 8.0). The NaOH
treated ghosts were divided into halves. A half of the ghosts were in-
cubated with 15 μg/ml trypsin at 37 °C for 30 min. After centrifuga-
tion again at 20,000×g for 30 min at 4 °C, the supernatant, which
contained digested peptides, was recovered. On the other hands, an-
other half of NaOH treated ghost were solubilized in a total volume
of 1 ml of 0.1 M Tris–HCl (pH 8) buffer containing 0.1% octaethylene-
glycol monododecyl ether (C12E8). The solubilized membrane was
digested with 4 μg/ml trypsin for 2 h at 37 °C. Liquid chromatogra-
phy/electron electrospray ionization mass spectrometry (LC/ESI-MS)
was carried out using a combination of HPLC (Waters 600E, Waters)
and a LCQ advantage ion trap mass spectrometer (Finnigan, San
Jose, CA, USA). The digested peptides were separated by HPLC using
a gradient of H2O (solvent A) and acetonitrile (solvent B), each con-
taining 0.1% formic acid at a ﬂow rate of 400 nl/min. The mobile
phase composition was held at 3% solvent B for 5 min, and then
ramped from 5% to 100% in 60 min and 85–100% in 20 min. For sepa-
ration of peptides in LC/ESI-MS, a C18 reversed-phase HPLC column
was used (L-column Micro; 0.075×50 mm; Chemicals Evaluation
and Research Institute, Japan). The column efﬂuent from the HPLC
separation was directed into the ESI source. The alkali and protease
resistance was calculated by the formula; [(the peak area of total
peptide)−(the peak area of the alkali and protease release pep-
tide)]/(the peak area of total peptide). Data were acquired and ana-
lyzed using LCQ version 2.0 software.
3. Results
3.1. Expression of AE1 mutants
Arg 901 mutants (R901K, R901E, R901A, R901M, R901C, and,
R901I) and alanine mutants in the C-terminal region (Leu 886-Val
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nine) were expressed on the yeast plasma membrane (Figs. 1 and 2).
Mutants expressing on the plasma membrane were quantiﬁed using
the protease accessibility assay as described previously [11,19]. We
measured the density of the 22-kDa N-terminal fragment bands,
which were produced by the cleavage of extracellular chymotrypsin.
Although chymotrypsin is large molecule, however some of large
molecules were able to pass through yeast cell wall [26]. Since
yeast vacuolar protein Vma2p was not digested by chymotrypsin
(Fig. 1 and Supplement Table 1), chymotrypsin inﬂuenced on only
plasma membrane band 3 [11]. We then estimated AE1 expression
on the plasma membrane (Fig. 1). The proportions of Arg 901 mu-
tants on the plasma membrane were nearly the same as those of
the wild type, indicating that Arg 901 mutation does not affect traf-
ﬁcking to the plasma membrane (Supplement Table 1). The approx-
imate amounts of AE1 mutants on the plasma membrane were
calculated and estimated as 40.5±16.3 μg per 1 l culture. In the
case of the peripheral alanine mutants, the bands of the 22-kDa N-
terminal fragments of D902A and P910A were not detected (Fig. 2B,
D). This indicates that there was no trafﬁc of D902A or P910A to
the plasma membrane. Previously, removal of only the last ﬁve
amino acids was enough to impair the proper trafﬁcking of AE1 in
HEK 293 cells [27]. Therefore, Asp 902 and Pro 910 are important res-
idues for proper trafﬁcking.
3.1.1. Kinetic parameters of sulfate transport of the C-terminal mutants
AE1-speciﬁc sulfate transport of Arg 901 mutants was measured
by 35SO42− incorporation according to our previous papers [11,19].
The sulfate ion incorporation of mutants is shown in Fig. 3A. It was
linear throughout the data collection period, which was more than
5 min (data not shown). In addition, sulfate incorporation was
correctly adjusted by the amount of each mutant expressed on the
plasma membrane. The amounts of sulfate ion incorporation in
R901K and R901E were similar to that of the wild type. On the
other hand, the amounts of sulfate ion incorporation in R901I,
R901M, and R901C mutants were lower than that of the wild type.
The [S/V]–[S] graph was plotted (Fig. 3B; S is the total sulfatewild-
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Fig. 1. Expression levels of Arg 901 mutants on the plasma membrane. Arg 901 mutants
were expressed in yeast. The yeast was treated without (−) or with 5 mg/ml chymotryp
antibodies. Whole-membrane domain and a 22-kDa N-terminal fragment of AE1 are ind
Vma2p antibodies (lower panel). An intracellular protein, Vma2p, was used as a proteaseconcentration and V is the velocity of sulfate incorporation at each
sulfate concentration). We then calculated the Vmax and Km values
(Table 1). Vmax values were determined by the reciprocal number
of intercepts on the vertical axis, and Km values were determined
by the slopes in the [S/V]–[S] graph. The coefﬁcient of determination
(r2) ranged from 0.976 to 0.941 on the [S/V]–[S] graph, indicating that
these kinetic parameters are obtained by plots having good linearity.
In addition, Km (23.7±5.9 mM) and Vmax (5.5±0.6 μmol/min per
mg AE1) values in the wild type were the same as the previous values
estimated by sulfate transport of AE1 in yeast cells (24.5±2.5 mM
and 5.7±0.9 μmol/min per mg AE1, respectively; [19]) and in red
blood cells (23 mM and 5.8 μmol/min per mg AE1 [28]).
Although the Km values for sulfate transport of AE1 mutants
slightly changed, however their values are similar to that of wild
type AE1 in comparison with those of His 834 mutants in the previous
study [11]. Since the Km values of His 834mutants increased about 5–
10-fold, thus we concluded that His 834 affects on substrate binding
[11]. Therefore, the similar Km values mean that the Arg 901 muta-
tion had little effect on the anion afﬁnity to the binding site in AE1.
In contrast, the Vmax values of mutants for sulfate transport differed
from that of the wild type. The Vmax values of R901M, R901C, and
R901I, in which Arg 901 was replaced with hydrophobic residues, de-
creased to 2.3±0.4, 2.1±0.2, and 1.7±0.2 μmol/min per mg AE1, re-
spectively. Their hydrophobic mutations signiﬁcantly affected on the
sulfate inﬂux (Fig. 3A). This shows that the mutation of Arg 901 to hy-
drophobic residue leads to the impairment of the sulfate ion transport
rate. Based on the ping-pong model, the rate of anion transport de-
pends on the rate of conformational change [11,19]. This indicates
that the impairment of Vmax value means inefﬁcient conformational
change. Moreover, we plotted the Vmax values of AE1 mutants
against ΔG as the hydrophobicity index, which is the transfer energy
of amino acids from organic solvent to water (Fig. 3C) [29,30]. The
plot was quite linear. This indicated that the conformational changes
in AE1 were affected by hydrophobicity at the 901st residue.
Furthermore, we evaluated the anion transport of a series of ala-
nine mutants in the C-terminal region (Leu 886-Val 911). Their kinet-
ic parameters were calculated in the same manner as in the Arg 901Whole 
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Fig. 2. Expression levels of alanine mutants of the C-terminal region on the plasma membrane. A series of alanine mutants of the C-terminal region were expressed in yeast. The
yeast was treated without (−) or with 5 mg/ml chymotrypsin (+). The extracts were immunoblotted with anti-Flag (upper panel) and anti-Vma2p (lower panel) antibodies. Fig-
ure A shows the results for L886A, D887A, D889A, D890A, K892A, and T894A. Figure B shows the results for F895A, D896A, E897A, E898A, E899A, G900A, and D902A. Figure C shows
the results for E903A, Y904A, D905A, and E906A. Figure D shows the results for V907A, M909A, P910A, and V911A.
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comparing those of His 834 mutants [11]. The Vmax values of
D887A, D889A, K892A, E897A, E898A, and R901A were decreased
(3.2, 4.4, 3.2, 3.2, 2.8 and 2.7 μmol/min per mg AE1, respectively) rel-
ative to the other peripheral mutants. These mutants reduced hydro-
philicity because hydrophilic residues were mutated to alanine. Thus,
the alanine mutation of hydrophilic residues Asp 887, Asp 889, Lys
892, Glu 897, and Glu 898 also could contribute in a fashion similar
to that of Arg 901.3.1.2. Increase in alkali and protease resistance by HPG or PG modiﬁca-
tion of Arg 901
We examined the alkali and protease resistance of the C-
terminal region after PG or HPG modiﬁcation using erythrocyte un-
sealed ghosts. HPG, a hydrophobic reagent, modiﬁed Arg 901 specif-
ically in AE1 [19]. HPG modiﬁcation at Arg 901 inhibited AE1 anion
transport because AE1 was ﬁxed to inward-facing conformation
[19]. PG also inhibited AE1 anion transport in a manner similar to
HPG [18] and PG is more hydrophobic than HPG because it lacks a
01
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Fig. 3. AE1-speciﬁc sulfate incorporation of yeast cells expressing Arg 901 mutants. (A)
Sulfate incorporation in AE1-expressing yeast cells against total sulfate concentration.
The cells containing the empty vector (cross), the wild type expressing cells (closed cir-
cle), R901C-expressing cells (open circle), R901I-expressing cells (open diamond),
R901K-expressing cells (closed triangle), R901E-expressing cells (closed square),
R901A-expressing cells (open triangle), and R901M-expressing cells (open square)
were pretreated with or without 10 μM DIDS. The cells were incubated in 5 to 160 mM
Na2SO4 containing 7.5 μCi of 35SO42− for 5 min at 30 °C. 35SO42− in cells was measured
by a scintillation counter. The difference in sulfate incorporated with and without DIDS
was calculated as the AE1-speciﬁc incorporation. Sulfate incorporation per 1 mg of AE1
expressed only on the plasma membrane is shown. (B) The [S/V]-[S] plot graphs were
calculated by the sulfate incorporation of each cell. The r2's, which were calculated
from the [S/V]–[S] plot, ranged from 0.976 to 0.941. (C) The correlation between Vmax
values of Arg 901 mutants and the hydrophobicity of the 901st residue. Vmax values of
Arg 901 mutants were plotted against the hydrophobicity index of amino acids of the
901st residue. The free-energy ΔG, which is the transfer of each amino acid from organic
solvents to water, was used as the hydrophobicity index [29,30].
Table 1
Kinetic parameters of the Arg 901 mutants. Kinetic parameters of the wild type and Arg
901 mutants are expressed as means±S.E. obtained from more than four experiments,
respectively. N are the numbers of independent measurements.
Band 3 Km (mM) Vmax (μmol/min per mg AE1) r2 N
Wild type 23.7±5.9 5.5±0.6 0.971±0.018 6
R901K 21.5±0.1 4.8±0.4 0.961±0.006 4
R901E 20.6±4.0 4.8±0.5 0.969±0.026 4
R901A 23.7±3.2 2.7±0.5 0.976±0.017 4
R901M 21.2±5.7 2.3±0.4 0.971±0.018 4
R901C 19.4±2.8 2.1±0.2 0.941±0.045 4
R901I 23.6±2.5 1.7±0.2 0.974±0.008 4
Table 2
Kinetic parameters of alanine mutants of C-terminal region.
Alanine mutants Km (mM) Vmax (μmol/min per mg AE1) Hydrophobicityb
L886A 26.8a 4.3 Decrease
D887A 14.8 3.2 Increase
(A888) - - -
D889A 23.9 4.4 Increase
D890A 30.6 5.7 Increase
(A891) - - -
K892A 17.2 3.2 Increase
(A893) - - -
T894A 31.6 8.0 Decrease
F895A 25.1 5.5 Decrease
D896A 28.0 5.8 Increase
E897A 18.1 3.2 Increase
E898A 16.8 2.8 Increase
E899A 26.1 4.9 Increase
G900A 24.8 5.4 Increase
R901A 23.7 2.7 Increase
D902A - - -
E903A 29.1 5.5 Increase
Y904A 23.2 5.3 Increase
D905A 27.7 5.4 Increase
E906A 20.3 4.8 Increase
V907A 27.4 5.1 Decrease
(A908) - - -
M909A 21.8 5.6 Decrease
P910A - - -
V911A 27.5 5.4 Decrease
a Each kinetic parameter calculated by one independent experiment.
b Change in hydrophobicity by alanine mutations.
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with HPG was saturated at 50 mM and that the other Arg residues
were not modiﬁed with HPG [19]. And the Ki of PG in aniontransport was 2.5 mM, which was ﬁve-fold lower than that of HPG
[18]. Therefore, the ghost was modiﬁed by 50 mM HPG and
10 mM PG.
Our previous reports suggested that, after alkali treatment at pH
13 (100 mM NaOH), AE1 was digested by trypsin and the digested
C-terminal peptide containing Arg 901 released from the membrane.
In contrast, after alkali treatment at pH 12 (10 mM NaOH), AE1 was
not digested and the peptide remained in the membrane [31–33]. In
the native membrane, as the NaOH concentration increased, the
protease resistance decreased greatly. After 50 mM NaOH treatment,
80% of the C-terminal peptide was released ([25], Supplement Fig.
1). Therefore, in this study, to evaluate the alkali and protease resis-
tance, we treated the unsealed ghosts with 50 mM NaOH after HPG
or PG modiﬁcation. The half of alkali-treated ghosts were solubilized
by C12E8, and the solubilized proteins were completely digested by
trypsin [10]. The solubilized and digested peptides were collected
as total peptides. And another half of the alkali-treated ghost was
directly incubated with trypsin at 4 °C for 30 min. After centrifuga-
tion, the supernatant fraction was collected as alkali and protease
released peptides. These digested peptides were analyzed and quan-
tiﬁed by LC/ESI-MS combined with reversed-phase HPLC. From
unmodiﬁed ghosts, we found the C-terminal peptide (m/z 1101.5,
amino acids 893–911; ATFDEEEGRDEYDEVAMPV), which was iden-
tiﬁed by MS/MS. In the HPG or PG treated ghost, we found mass
peaks derived from the HPG and PG modiﬁed peptide (mz 1174.7
663S. Takazaki et al. / Biochimica et Biophysica Acta 1818 (2012) 658–665and 1165.8), respectively. The unmodiﬁed peak could not be seen in
the analysis of the HPG or PG treated ghost. Therefore, Arg901 was
modiﬁed with HPG or PG] PGLC/ESI-MS were modiﬁed with Arg901
completely under our modiﬁcation condition. Fig. 4A shows selected
ion chromatograms of the alkali and protease released peptides from
the modiﬁed and unmodiﬁed membrane. And then we calculated
the alkali and protease resistance using the eluted peak area of alkali
and protease released peptides and total peptides (Fig. 4B). In the
native membrane, after 50 mM NaOH and trypsin treatment, only
20% of the C-terminal peptide was remained in membrane. This was
consistent with our previous and the reversed phase-HPLC results
using resealed ghost ([25] and Supplement Fig. 1). On the other
hand, 50% or 60% of the C-terminal peptide remained in the HPG or
PG treated membrane, respectively. It indicates that the alkali and
protease resistance of the C-terminal peptide increased in the HPG
or PG modiﬁed membrane. Thus, we found that the hydrophobic
modiﬁcation of the 901st residue induced a more alkali and protease
resistant structure in the C-terminus of AE1.
4. Discussion
To further clarify Arg 901's role, we expressed various AE1 mu-
tants of the 901st residues, such as basic (R901K), acidic (R901E),R
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Fig. 4. Alkali and protease resistance of the C-terminal region after HPG or PG treatment. (
separation of tryptic-digested C-terminal peptides. White ghosts were pretreated with 0, 50
NaOH and then were digested with 15 μg/ml trypsin at 37 °C and pH 8.0 for 30 min. Their pe
and acetonitrile (solvent B), at a ﬂow rate of 400 nl/min. The chromatograph of unmodiﬁed (le
by the molecular ions, m/z 1171.6, 1174.7 and 1165.8, respectively. (B) The alkali and proteas
membranes. Alkali and protease resistance was calculated by the peak area between alkali andand hydrophobic mutants (R901M, R901C, and R901I) on the
yeast plasma membrane and evaluated the kinetic parameters.
Vmax values of the hydrophobic mutants of Arg 901 decreased
while the Km values of all mutants not so changed. Furthermore,
we found a clear relationship between the Vmax values of sulfate
transport in Arg 901 mutants and the hydrophobicity of the 901st
residue in the mutants (Fig. 3C). Thus, we concluded that the hy-
drophobicity of the 901st residue was related to the anion ex-
change in AE1. The mutants to glutamate and lysine did not
reduce the Vmax values, indicating that a positive or negative
charge of the 901st residue did not inﬂuence anion transport.
Under higher pH (>pH 12) conditions, Arg 901 residues are hydro-
phobic by the occurrence of de-protonation of the guanidino group
of Arg. This idea may be a cause of the pK value 12 of chloride ex-
change in AE1 [15].
Furthermore, we evaluated the kinetic parameters of a series of al-
anine mutants in the C-terminal region (Leu 886–Val 911). Similar to
the case with the R901A mutant, since the Km values of the alanine
mutants were not so changed. Some mutations slightly affect on Km
values (increase: T894A, decrease: D887A, K892A, E898A). Possibly,
the corresponded residues may interact with substrate binding site
(i.e. His 834, [11]) by alanine mutation and then affect on the sub-
strate binding. On the other hand, the Vmax values of D887A,40 50 60
0
20
40
60
80
100
0 60
G PG
PG PG
n time (min) Retention time (min)
A) Selected ion chromatograms from ESI-MS detection of the peaks eluted from HPLC
mM HPG or 10 mM PG. The HPG or PG pre-treated ghosts were incubated with 50 mM
ptides were separated by LS/ESI-MS using a gradient of an aqueous solution (solvent A)
ft), HPG-modiﬁed (center) and PG-modiﬁed C-terminal peptides (right) were generated
e resistance of the C-terminal region in unmodiﬁed (no treatment), HPG or PG modiﬁed
protease released peptide and total peptide (see in the text).
664 S. Takazaki et al. / Biochimica et Biophysica Acta 1818 (2012) 658–665K892A, E897A, and E898Amutants decreased (Table 2). Therefore, we
claimed that the increased hydrophobicity resulting from the alanine
mutation at the C-terminal region, especially the hydrophilic part of
the Asp 887–Arg 901 region, caused the impairment of anion trans-
port. The decrease of anion transport activity seemed to occur in
every two or three residues. It may be involved in helical conforma-
tion of its C-terminal region. Vmax residue of Thr 894 mutant was in-
creased. It may be caused by deletion of γ-methyl group, which was
important for hydrophobic interaction in native AE1 structure.
HPG or PG modiﬁcation increases the hydrophobicity of arginine
because HPG or PG confers the phenyl group to arginine and elimi-
nates the positive charge from arginine. When HPG modiﬁed Arg
901, changes from inward-facing to outward-facing conformation
were inhibited, leading to the inhibition of anion transport [19]. The
present study showed that the C-terminal region of HPG- or
PG-modiﬁed AE1 was more alkali-resistant on the erythrocyte
membrane than that of native AE1 (Fig. 4B). Furthermore, the more
hydrophobic reagent, PG, was slightly more effective than HPG.
Hamasaki suggested that alkali-sensitive structures, which have
peptide-peptide interaction, are essential for the ﬂexible conforma-
tional change involved in anion transport [33,34]. Thus, the change
in the C-terminal region to the alkali-resistant structure by hydropho-
bic interaction caused low ﬂexibility in the structure and then inefﬁ-
cient conformational change. In our previous and present mutant
studies, we also revealed the decrease in Vmax values in a part of
C-terminal hydrophobic mutants. Together with these results, we
concluded that the additive hydrophobicity in the C-terminal tail in
AE1 modulated the anion exchange involved in conformational
change. The previous C-terminal truncation mutant study of AE1
suggested that 21 amino acids following Ala 891 were not needed
anion exchange activity [35,36]. Thus, hydrophobic mutation or
modiﬁcation of C-terminal residues may produce new interaction in
the AE1 structure, leading to a structure with little ﬂexibility.
Our previous and present studies suggested that the increase in
C-terminal hydrophobicity leads to a series of changes: hydrophobic
interaction between the C-terminal and other regions, the ﬂexible
C-terminal region change to an alkali-resistant and low-ﬂexibility
structure, inefﬁcient conformational change by the ﬁxation of an
inward-facing conformation, and the inhibition of anion transport.
Our results will be valuable for understanding in greater detail the
mechanism underlying the conformational change involved in AE1
anion transport when the structures are solved in the future.
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